维普期刊资源整合服务平台（V6.5）

84篇 您的检索式：作者名="J Markman"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	A prospective study of salivary function sparing in patients with head-and-neck receiving intensity-modulated or three-dimensional radiation therapy: initial results 显示文摘	Chao K S Deasy J O Markman J	2001	Int J Radiat Oncol Biol Phys2001，49，4：	1
2	Targeting the PI3K/Akt/mTOR pathway–beyond rapalogs显示文摘	Markman B Dienstmann R Tabernero J	2010	Oncotarget2010，1，7：	1
3	A prospective study of salivary function sparing in patients with headand-neck cancers receiving intensity-modulated or threedimensional radiation therapy:initial results显示文摘	Chao KS Deasy JO Markman J	2001	Int J Radiat Oncol Biol Phys2001，49，4：	1
4	Targeting thePI3K/Akt/mT0R pathway-beyond rapalogs 显示文摘	Markman B Dienstmann R Tabernero J	2010	Oncotarget2010，1，：	1
5	An outbreak of Yersini- aenterocolitica 0 : 8 infections associated with pasteurised milk 显示文摘	Ackers ML S Schoenfeht J Markman	2000	J In - feet Dis2000，181，：	1
6	A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation thera- py: initial results显示文摘	Chao KS Deasy JO Markman J	2001	Int J Radiat Oneol Binl Phys2001，49，4：	1
7	Patient flow in neuropathic pain management:understanding existing patterns of care显示文摘	Markman J D Dukes E Siffert J	2004	Eur J Neurol2004，11，2：	1
8	Targeting the PI3K/Akt/mTOR pathway-beyond rapalogs 显示文摘	Markman B Dienstmann R Tabemero J	2010	Oncotarget2010，1，7：	1
9	Phase II trial of weekly paclitaxel(80 mg/m2)in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers:a Gynecologic Oncology Group study显示文摘	Gynecologic Oncology Group Markman M Blessing J	2006	Gynecol Oncol2006，101，3：	1
10	Uncertainties in outcome model predictions 显示文摘	Deasy J O Chao K S Markman J	2001	Radiation Oncology Biology Physics2001，51，5：	1
11	Phase II trial of weekly paclitaxel (80 mg/m^2) in platinum and paclitaxel- resistant ovarian and primary peritoneal cancers: a Gynecologic OncologyGroup Study显示文摘	Markman M Blessing J Rubin S C	2006	Gynecol Oncol2006，101，3：	1
12	Design by analogy :a Study of the wordtree method for problem re-representation 显示文摘	Linsey J S Markman A B Wood K L	2012	Journal of Mechanical Design2012，134，04：	1
13	A prospective study of Salivary function sparing in patients with headandneck cancers receiving intensitymodulated or threedimensional radiation hera- pydnitial results显示文摘	Chao KSC Deasy JO Markman J	2001	Int J Radiat Oncol Biol phys2001，49，4：	1
14	A prospective study of salivary function sparing in patients with head-and-neck cancer receiving intensity-modulated or three-dimensional radiation therapy:initial results显示文摘	Chao KS Deasy JO Markman J	2001	Int J Radiat Oncol Biol Plays2001，49，4：	1
15	EGFR and KRAS in colorectal cancer显示文摘	Markman B Javier Ramos F Capdevila J	2010	Adv Clin Chem2010，51，：	1
16	A prospective study of salivary function sparing in patients with head- and-neck cancers receiving intensity-modulate (or three- dimensional radiation therapy) : initial results显示文摘	Chao K S Demy J O Markman J	2001	Int J radiat Oncol Biol Phys2001，49，4：	1
17	Phase trial of weekly single-agent paclitaxel in platinum/paclitaxel-refractory ovarian cancer 显示文摘	Markman M Hall J Spitz DW	2002	J Clin Oncolj2002，20，9：	1
18	Similar and different:the differentiation of basic-level categories显示文摘	MARKMAN A B WISNIEWSKI E J	1997	Journal of ex- perimental psychology: learning memory and cognition1997，23，1：	1
19	Toward automated quality assurance for intensity-modulated radiation therapy显示文摘	Low DA Dempsey JF Markman J etal	2002	Int J Radiat Oncol Biol Phys2002，53，2：	1
20	Phase II trial of weekly paelitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovari- an and primary peritoneal cancers: a Gynecologic Oncology Group study显示文摘	Markman M Blessing J Rubin SC	2006	Gynecol Oncol2006，101，3：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示